Never ever a 483?

We can not promise that you will never get a 483
but we know that the GMP MANUAL includes all 
procedures and processes you need to be
GMP compliant.
Stay informed!

If you’d like to be regularly informed of the latest developments at Good Manufacturing Practices


>>> simply register for our free GMP newsletter LOGFILE



TOP 5 GMP Downloads

1. GDP Audit Checklist
for the Storage and Transport of Pharmaceuticals


2. Quality Agreement
Standard draft to adapt and extend


3. Premises
Official requirements | material flow | room classes | and much more...


4. GMP Audit Checklist
for Pharmaceutical and API Manufacturers


5. Documenting Process Validation
A Drugmaker‘s Guide – step-by-step manual based on real-world examination experience


Your benefits:

> no shipping costs
> no waiting period: if you choose payment by credit card you will receive an email with the download information immediately after payment.


>>> Click here to find more Downloads!


News about GMP/cGMP


On January 12, 2010, as the first phase of the agency's Transparency Initiative, FDA launched a web-based resource called FDA Basics that provides basic information about the agency and how it does its work.


An informal Working Group within PIC/S has developed an example of methodology for the implementation of Quality Risk Management (QRM) in the pharmaceutical industry.


EMA (EMEA) has published their 2010 Work Plan for the GMP/ GDP Inspectors Working Group on January 12, 2010. Among other themes, there are several GMP and GDP topics concerning the EU GMP Guide identified as "high priority"  in 2010. Topics with "low priority" and all further informations concerning the Work Plan for 2010 you find in the document linked below.


The European Commission's Draft Group Enterprise and Industry launches a public consultation on Part III of the good manufacturing practices laying down guidance to manufacturers in preparing site master files. The European Commission published this draft document on January 12, 2010. The consultation period ends on March 31, 2010.


EMA (former EMEA) is currently updating chapters 3 and 5 of the EU GMP Guide concerning self-contained facilities for critical products. In some circumstances it is necessary to manufacture certain products in dedicated and self-contained facilities where the risks to patients posed by accidental cross contamination of other products is high.

Despite the the documents are still in revision, there are already some points to consider:


Due to a revision of Chapters 1 and 2 of the EU GMP Guide in 2010 there should be an alignment with the concepts described in ICH Q10.


From 8 December 2009 onwards, the 'emea' part of the European Medicines Agency's website and e-mail addresses is replaced with 'ema'.


The Maas & Peither team would like to thank you for your continuous patronage. At this point we would like to especially thank the numerous partners and authors which are supporting us to keep our products up to the highest standards - so that our clients have the latest information at hand. We could not do this without you!

Season's Greetings and a prosperous New Year

Your Maas & Peither Team

Page 39/48    35   36   37   38   39   40   41   42   43   44  

Maas & Peither AG
GMP Publishing

Karlstraße 2
79650 Schopfheim

Tel. +49 (0) 7622 6 66 86 70
Fax +49 (0) 7622 6 66 86 77